Its consolidated rupee revenue came in around a percent lower at Rs 7,495 crore, while its dollar revenue came in higher by over a percent at USD 1,131.2 million.
Street carries on bullish momentum, led by a rally in midcaps and steady earnings from index majors. Pharma stocks continue freefall post poor Q4 and sector outlook.
The company had posted a net profit of Rs 105.54 crore during the same period of previous fiscal, Birla Corporation said in a BSE filing.
Total income declined to Rs 3,079.47 crore in the January-March quarter of the 2016-17 fiscal from Rs 3,618.14 crore in the year-ago period.
The company had posted a net profit of Rs 2,380.68 crore for the January-March quarter of last fiscal, ITC said in a BSE filing.
The company had reported a profit after tax of Rs 24.10 crore in the year-ago quarter, it said in a BSE filing.
The company had posted a net profit of Rs 20.95 crore during the January-March quarter of previous fiscal, Indoco Remedies said in a BSE filing.
The company had posted a net profit of Rs 306.21 crore in the year-ago quarter, CONCOR said in a BSE filing.
The rally, which started with expectation of pro-growth reforms from the Modi-government is likely to stretch towards 2019 because most analysts and fund managers see Modi 2.0.
The company had reported a net profit of Rs 13.1 crore during the same period of previous fiscal, Greenlam Industries said in a statement.
The company booked order of USD 365 million or about Rs 2,300 crore in 2016-17, of which USD 90 million or around Rs 500 crore worth orders were booked in January-March.
Street ends the session on an extremely strong note, driven by a rally in midcaps as well as private banks. However, pharma stocks sulked the most on poor earnings, sectoral outlook.
The company had posted net profit of Rs 2.64 crore in the corresponding quarter of the fiscal 2015-16.
Total income from operations rose to Rs 753.39 crore in the fourth quarter of last fiscal from Rs 544.57 crore in the year-ago period.
The company's total income also fell to Rs 4,729.75 crore in the last fiscal from Rs 4,979.66 crore in the 2015-16 fiscal.
Total income of the company rose to Rs 905.50 crore in the last quarter of 2016-17, from Rs 655.48 crore in the same quarter of previous fiscal, Manappuram Finance said in a statement.
Total income of the company rose to Rs 1,274.7 crore in the last quarter of FY2016-17, from Rs 1,048.5 crore in the same quarter of the previous fiscal, GE T&D said in a statement.
Leading stock exchange BSE will delist as many as 61 firms from its platform from May 29 as they have remained suspended for more than 13 years.
Intense buying boosts Street, with Sensex ending over 440 points higher, while the Nifty gains nearly 150 points. Bank Nifty and midcaps gain on expiry day, pushing the indices higher.
The recent set of results highlights the ills of the sector. Pharmaceutical companies are having a tough time with the US authorities pulling them up regularly for irregularities at one end, while on the other hand the companies are taking a hit on the revenue front at the international and domestic front.
The Coimbatore-based company had recorded a net loss of Rs 1.45 crore during the corresponding quarter of previous year.
Total income increased to Rs 2,208.91 crore in the January-March quarter of the 2016-17 fiscal, from Rs 1,884.19 crore in the year-ago period. Revenue from domestic sales increased by 23 per cent to Rs 1,606.19 crore from Rs 1,310.71 crore, but the income from exports remained flat at Rs 551.93 crore as against Rs 560.67 crore in the said period.
The company had posted a standalone net profit of Rs 490.6 crore in the same period of previous fiscal, Bosch Ltd said in a BSE filing.
The newly commissioned unit is part of RattanIndia Nasik Power Ltd's 5x270 MW thermal power project.
"The Board of Directors of the company have on May 25, 2017 by circular resolution taken note of Arvind Uppal's decision to step down from employment of the company with effect from January 1, 2018," Whirlpool of India said in a BSE filing.